Showing results (181-190 of 259) with videos related to
Sort By:
Pageof 26
Psychopharmacology|August 3, 2000
Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophreniaS J Cooper, A Butler, J Tweed, et al.Physiology & Behavior|January 1, 1987
Partial agonists acting at benzodiazepine receptors can be differentiated in tests of ingestional behaviourS J Cooper, R E Yerbury, J C Neill, et al.The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1991
The clinical correlates of neurological soft signs in chronic schizophreniaD J King, A Wilson, S J Cooper, et al.Journal of Psychopharmacology (Oxford, England)|December 14, 2011
Serum haloperidol levels and clinical response in chronic, treatment-resistant schizophrenic patientsF W Browne, S J Cooper, R Wilson, et al.European Journal of Pharmacology|October 27, 1987
CGS 8216 treatment decreases central-type benzodiazepine receptors in rat brainJ Deckert, L B Estall, P J Marangos, et al.The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1988
The effect of electroconvulsive therapy on CSF amine metabolites in schizophrenic patientsS J Cooper, W Leahey, D F Green, et al.Chemical Science|November 25, 2022
Structured ternary fluids as nanocrystal incubators for enhanced crystallization controlJ J Maunder, J A Aguilar, P Hodgkinson, et al.Acta Psychiatrica Scandinavica|March 18, 2000
A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophreniaS J Cooper, J Tweed, J Raniwalla, et al.Neuropharmacology|September 1, 1985
Effects of tifluadom on food consumption compared with chlordiazepoxide and kappa agonists in the ratS J Cooper, W R Moores, A Jackson, et al.Patient Education and Counseling|March 15, 2021
Experiences and attitudes of hereditary cancer screening patients in a consumer directed testing modelV Greve, M Garner, K Odom, et al.Pageof 26